Amin Rakesh, Williams Rachel M, Frystyk January, Umpleby Margot, Matthews David, Orskov Hans, Dalton R Neil, Dunger David B
University Department of Paediatrics, Addenbrookes Hospital, Cambridge, UK.
Clin Endocrinol (Oxf). 2005 Feb;62(2):137-44. doi: 10.1111/j.1365-2265.2005.02185.x.
We previously described lower insulin-like growth factor I (IGF-I) levels in association with increased microalbuminuria (MA) risk in type 1 diabetic subjects followed from diabetes diagnosis through puberty into adulthood. By inference lower IGF-I levels may be associated with higher GH levels and changes in insulin sensitivity.
To test this hypothesis, microalbuminuric subjects (MA+, n = 14) from the same cohort had overnight GH levels measured during euglycaemia (5 mmol/l, 01:00-07:30 h) maintained by a variable rate insulin infusion followed by a 2-step hyperinsulinaemic, euglycaemic clamp study using [6.6 2H2] glucose, and were compared to MA- controls (MA-, n = 14), matched for age (median 19.3 years, range 15.8-30.5), sex, duration of diabetes (11.1 years, range 5.1-16.4).
In MA+ cases GH levels, measured by the Pulsar programme, were higher (baseline; 1.8 +/- 1.4 vs. 0.7 +/- 0.5 ng/ml, P = 0.02, mean; 3.8 +/- 1.3 vs. 2.6 +/- 1.6 ng/ml, P = 0.03, maximum; 16.7 +/- 7.0 vs. 12.3 +/- 5.4, P = 0.02), despite similar HbA1(c) levels (9.8%vs. 9.6%, P = 0.6) and body or truncal fat mass. Fourier transform revealed increased GH pulse amplitude at all periodicities and overnight insulin clearance was reduced (11.7 +/- 6.9 vs. 20.1 +/- 6.5 ml/kg/min, P < 0.02). In multiple regression analysis, urine albumin excretion was associated with higher GH levels and reduced insulin clearance, independent of HbA1(c) and body composition. In female cases (n = 9), dextrose requirements were reduced during the first step of the euglycaemic clamp (1.7 +/- 0.8 vs. 2.7 +/- 1.4, P < 0.05) but no such differences existed in males or in the rate of glucose production or disposal.
The development of MA during puberty and young adulthood is associated with higher GH levels and abnormalities in insulin metabolism, particularly in females. These data extend support for our previous findings indicating a role for the GH/IGF-I axis in the pathogenesis of MA.
我们之前描述过,在1型糖尿病患者中,从糖尿病诊断开始,历经青春期直至成年,胰岛素样生长因子I(IGF-I)水平较低与微量白蛋白尿(MA)风险增加相关。由此推断,较低的IGF-I水平可能与较高的生长激素(GH)水平及胰岛素敏感性变化有关。
为验证这一假设,对同一队列中的微量白蛋白尿患者(MA+,n = 14)在血糖正常(5 mmol/l,01:00 - 07:30 h)状态下进行夜间GH水平测量,通过可变速率胰岛素输注维持血糖正常,随后采用[6.6 2H2]葡萄糖进行两步高胰岛素正常血糖钳夹研究,并与MA-对照组(MA-,n = 14)进行比较,两组在年龄(中位数19.3岁,范围15.8 - 30.5)、性别、糖尿病病程(11.1年,范围5.1 - 16.4)方面相匹配。
通过Pulsar程序测量,MA+患者的GH水平更高(基线:1.8 ± 1.4 vs. 0.7 ± 0.5 ng/ml,P = 0.02;均值:3.8 ± 1.3 vs. 2.6 ± 1.6 ng/ml,P = 0.03;最大值:16.7 ± 7.0 vs. 12.3 ± 5.4,P = 0.02),尽管糖化血红蛋白A1c(HbA1c)水平(9.8% vs .